Premium Healthcare Group (CAI:PHGC) Debt-to-Equity: 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Premium Healthcare Group Debt-to-Equity?

Premium Healthcare Group CAI:PHGC Debt-to-Equity is 0.00 as of . 20. Among 181 Medical Diagnostics & Research companies, Premium Healthcare Group ranks worse than 552485.64% on this metric.

Premium Healthcare Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was E£0.00 Mil. Premium Healthcare Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was E£0.00 Mil. Premium Healthcare Group's Total Stockholders Equity for the quarter that ended in . 20 was E£0.00 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Premium Healthcare Group's Debt-to-Equity or its related term are showing as below:

CAI:PHGC's Debt-to-Equity is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.28
* Ranked among companies with meaningful Debt-to-Equity only.

Premium Healthcare Group  (CAI:PHGC) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Premium Healthcare Group Debt-to-Equity Related Terms

Premium Healthcare Group Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for Premium Healthcare Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Premium Healthcare Group Debt-to-Equity Chart

Premium Healthcare Group Annual Data
Trend
Debt-to-Equity

Premium Healthcare Group Semi-Annual Data
Debt-to-Equity

CAI:PHGC vs TMO, DHR, NTRA: Debt-to-Equity Comparison

For the Diagnostics & Research subindustry, Premium Healthcare Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Premium Healthcare Group Debt-to-Equity vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Premium Healthcare Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Premium Healthcare Group's Debt-to-Equity falls into.


Premium Healthcare Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Premium Healthcare Group's Debt to Equity Ratio for the fiscal year that ended in . 20 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=( + ) / N/A
=N/A

Premium Healthcare Group's Debt to Equity Ratio for the quarter that ended in . 20 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=( + ) /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Equity →
What does a Debt-to-Equity of 0.00 mean?
Premium Healthcare Group (CAI:PHGC) has a Debt-to-Equity of 0.00 as of . 20. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Premium Healthcare Group and its competitors. According to the industry distribution chart, Premium Healthcare Group ranks #999999 out of 181 companies in the Medical Diagnostics & Research industry.
Is Premium Healthcare Group's Debt-to-Equity too high?
Premium Healthcare Group's current Debt-to-Equity is 0.00. Based on the distribution chart, Premium Healthcare Group ranks #999999 out of 181 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Premium Healthcare Group's Debt-to-Equity compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Premium Healthcare Group ranks #999999 out of 181 companies for Debt-to-Equity. This places Premium Healthcare Group in the lower half of its industry. The industry median Debt-to-Equity is 0.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Diagnostics & Research company?
The median Debt-to-Equity among Medical Diagnostics & Research companies is 0.28, based on 181 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Premium Healthcare Group and its competitors. For the Medical Diagnostics & Research industry, the median Debt-to-Equity is 0.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Premium Healthcare Group's current Debt-to-Equity is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Premium Healthcare Group stock overvalued right now?
Premium Healthcare Group (CAI:PHGC) has a current Debt-to-Equity of 0.00. The current Debt-to-Equity is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Premium Healthcare Group (CAI:PHGC), the current Debt-to-Equity is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Premium Healthcare Group Business Description

Address 5 El Dakahlia, El Nasr Street, Port Said, EGY
Premium Healthcare Group Formerly City Lab is a company whose main purpose is to establish, operate and manage medical analysis laboratories, and import supplies and equipments, medical analysis laboratories.